CONCLUSIONS AND RELEVANCE Imaging by the ETDRS 7-field and UWF imaging systems have moderate to substantial agreement when determining the severity of DR within the 7 standard fields. Disparities in an individual eye are equivalently distributed between imaging modalities and can be better or worse on 1 or the other. Longitudinal follow-up will evaluate the primary outcome of this study to determine if peripheral retinal findings are associated with future retinopathy outcomes.
F or 2 decades, the standard for determining severity of diabetic retinopathy (DR) has been the extended modified Airlie House classification used in the Early Treatment Diabetic Retinopathy Study (ETDRS). 1 In this defined classification system, the location and extent of specific retinal lesions are evaluated in the posterior pole, using 7 stereoscopic pairs of photographs per eye (ETDRS 7 standard fields). The DR severity determined in this manner is highly correlated with the risk of DR progression. 2 Current DR therapeutic and management guidelines are based on clinical trials using the ETDRS classification system. A condensed version of this classification has been proposed internationally for general clinical DR assessment.
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Substantial diabetic retinal pathology can exist in the retinal periphery located outside the ETDRS 7 standard fields, which in total compose about 34% of the retinal surface. [4] [5] [6] Advances in retinal imaging technology now allow ultrawidefield (UWF) cameras to evaluate up to 82% of the retinal surface in a single image. 7 Several single-center studies have suggested moderate to substantial agreement between UWF and ETDRS imaging. [8] [9] [10] Furthermore, UWF studies have shown that DR occurs in areas peripheral to the ETDRS fields in up to 40% of eyes and is extensive enough to imply a more severe level of DR in 9% to 15% of eyes. 5, [11] [12] [13] This study is a preplanned cross-sectional analysis of baseline data from an ongoing 4-year evaluation of 764 eyes of 385 participants to assess how the retinal far periphery observed using mydriatic UWF images (with a 200°view) affects the ability to assess DR severity and is associated with rates of DR worsening over time compared with ETDRS 7-field imaging. Severity grading between the ETDRS 7-field and UWF images within the ETDRS 7-field area was compared to assess whether UWF images can be used reliably in place of ETDRS imaging in future clinical trials. We also evaluated the peripheral area in the UWF images to determine presence, type, severity, and location of DR lesions outside the ETDRS 7-field area and how these peripheral lesions might change grading of DR severity compared with ETDRS images.
Methods
This study is a prospective observational study conducted by the Diabetic Retinopathy Clinical Research Network (DR-CR.net) at 38 clinical sites in the United States and Canada. (The protocol, labeled AA, can be found at http://drcrnet. jaeb.org.) The study adhered to the tenets of the Declaration of Helsinki and was approved by multiple institutional review boards. Study participants provided written informed consent.
Enrolled participants were adults (≥18 years) with type 1 or type 2 diabetes. Study eyes had nonproliferative DR (NPDR; defined as ETDRS retinopathy severity at levels 35 through 53), no history of panretinal photocoagulation, and no centralinvolved diabetic macular edema on optical coherence tomography, based on DRCR.net sex-based and machine-based thresholds or clinical examination.
14 This article includes data from the eyes included in the study (n = 579) and additional nonstudy eyes (n = 185) that had available ETDRS and UWF images at baseline.
Image Acquisition
At baseline, after pupil dilation, ETDRS 7-field stereoscopic images, UWF images, and a fundus examination were performed on both eyes of each participant. Fundus photographs were obtained based on the DRCR.net image acquisition procedure. The UWF images were obtained using the Optos 200Tx (Optos, PLC). The UWF imaging procedure included two 200°central images and four 200°steered images. In the present report, only the central images were evaluated. The professionals capturing ETDRS 7-field images were certified by the Fundus Photograph Reading Center at the University of Wisconsin, and those capturing UWF images were certified by Optos, PLC.
Image Grading
Ultrawide-field and ETDRS 7-field images were transferred digitally to the Joslin Diabetes Reading Center (Boston, Massachusetts) for standardized grading by 3 senior readers masked to all clinical characteristics and the grading of the other imaging modality. All readers had extensive experience grading retinopathy images (range, 14-37 years). To ensure reproducibility, all grading was performed using high-resolution displays that are color calibrated and gamma corrected biannually. More than 43 000 UWF images have been evaluated by the reading center. Grader agreement for DR severity (weighted κ) was 0.88 to 0.93 for UWF images and 0.83 to 0.84 for ETDRS 7 standard field images. 15 Using images that were not part of this study, agreement between the 2 primary readers for UWF vs ETDRS images was substantial (κ, 0.80 ± 0.13).
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An individual reader graded either UWF or ETDRS images but never both modalities for the same eye. When grading the UWF images, images were initially presented with a template mask, which had been digitally overlaid automatically to obscure the retinal periphery such that only the ETDRS 7-field area was visible (UWF masked; Figure 1A ). After complete grading of the UWF-masked image, the mask was removed, and the full image including the UWF periphery was evaluated (UWF unmasked; Figure 1B ).
Key Points
Question Is ultrawide-field imaging comparable with Early Treatment Diabetic Retinopathy Study (ETDRS) imaging when assessing the severity of diabetic retinopathy within the 7 standard fields? Findings In this cross-sectional study, there were 737 gradable eyes on both ETDRS 7-field images and ultrawide-field images masked to contain the same 7 fields after adjudication; 435 eyes (59.0%) had exact agreement, and 714 eyes (96.9%) were within 1 step of agreement.
Meaning These findings could justify ultrawide-field imaging for assessing the severity of diabetic retinopathy end points in future studies.
The UWF images stereographically projected by Optos software were used to determine DR severity. For all 3 image approaches, the presence and severity of the following lesions were assessed in temporal, superior temporal, inferior temporal, superior nasal, and inferior nasal fields (fields 3-7): hemorrhages and/or microaneurysms, intraretinal microvascular abnormalities, venous beading, new vessels on the disc, new vessels elsewhere, hard exudates, retinal thickening, preretinal hemorrhage, vitreous hemorrhage, traction retinal detachment, and central fields.
For the unmasked UWF images, each lesion type was characterized as (1) not observed, (2) predominantly observed within the ETDRS fields, (3) predominantly observed outside the ETDRS fields, or (4) observed uniformly distributed within and outside the ETDRS fields, or (5) ETDRS field obscured, (6) periphery obscured, or (7) ungradable. For each field, a lesion was considered predominantly peripheral if more than 50% of the lesion was observed in the retinal periphery compared with the area within the modified ETDRS fields. A lesion was considered uniformly distributed if it was equivalently located both within and outside the ETDRS field. A lesion was considered predominantly posterior if 50% of the lesion was within the modified ETDRS fields.
Based on the extent and severity of the lesions, a composite ETDRS DR grade was derived: no DR (level 10-12), minimal NPDR (level 14-20), mild NPDR (level 35), moderate NPDR (level 43), severe NPDR (level 47-53), very severe NPDR (level 53E), inactive proliferative DR (PDR) (level 60), non-high-risk PDR (level 61-65), and high-risk PDR (level 71-75). Proliferative DR was defined as new vessels in at least 1 field. In the absence of new vessels, if the eye had NPDR characteristics in at least 1 field, then the eye was considered to have NPDR regardless of any areas obscured. An eye was classified as having no DR if all fields were gradable and did not have DR characteristics. Sensitivity analyses using other approaches for missing fields (eg, assessing only eyes with data available for at least 3 fields) did not appreciably change the results.
The ETDRS 7-field and UWF masked images do not necessarily visualize the exact same retinal area because of asynchronous image capture and the unique imaging methodology of each instrument. Thus, preplanned side-by-side adjudication of all eyes with DR severity differing by 2 or more steps between the ETDRS and UWF masked imaging was performed by a senior grader (L.P.A.), who was not involved in prior grading, to assess the reasons underlying the discrepancy, including grader error, suboptimal image quality, or differences in visualized areas. The senior grader also determined from all available image information which modality provided the overall more accurate DR severity grade (recorded as "ETDRS more accurate," "UWF more accurate," or "modalities similar").
Statistical Analyses
Percentages and 95% CIs were calculated using generalized estimating equations to account for the correlation between eyes of the same participant. Levels of agreement were calculated using κ statistics. For multilevel outcomes, quadratic weights were used to estimate κ statistics and 95% CIs. Strength of agreement beyond chance alone was determined using the Landis and Koch interpretation of κ statistics (0.20 indicates slight agreement; 0.21-0.40, fair agreement; 0.41-0.60, moderate agreement; 0.61-0.80, substantial agreement; and 0.81-1.00, almost perfect agreement). A sensitivity analysis was conducted to adjust for the correlation between eyes of the same participant, but the results did not change appreciably. 16 All statistical analyses were conducted using SAS version 9.4 (SAS Institute Inc). Figure 2A ). Discrepancies of 2 or more steps were equally distributed between ETDRS and UWF masked images. Figure 2B ).
Comparison After Adjudication
Among adjudicated images, the ability of ETDRS and UWF masked images to accurately detect retinopathy was considered equivalent in 59 eyes (50.9% [95% CI, 41.3%-60.4%]), ETDRS 7-field images were considered more accurate in 22 eyes (19.0% [95% CI, 12.5%-27.7%]), and UWF masked images were considered more accurate in 31 eyes (26.7% [95% CI, 18.8%-36.5%]). For the 59 eyes with similarly accurate images, grading error was the major reason for the difference, which was equivalently distributed between ETDRS images (n = 25) or UWF masked images (n = 29). When either ETDRS images (n = 22) or UWF masked images (n = 31) were identified as the more accurate modality, the major reason for the difference was suboptimal image quality of the other modality (UWF, n = 17; ETDRS, n = 27). The distribution of the lesions underlying these differences is in eTable 3 in the Supplement.
Additional Lesions Observed in the Retinal Periphery by UWF Imaging
There were 751 gradable eyes on both UWF masked and UWF unmasked images. 
Distribution of Predominantly Peripheral Lesions
Lesions were observed in 4504 fields: 2312 (51.3%) were predominantly within the ETDRS fields, 660 (14.7%) were predominantly peripheral to the ETDRS fields, and 1532 (34.0%) were uniformly distributed. Of these fields, 3056 had hemorrhages and/or microaneurysms, with 458 fields (15.0%) predominantly peripheral; 1299 intraretinal microvascular abnormalities, with 168 fields (12.9%) predominantly peripheral; 110 venous beading, with 13 fields (11.8%) predominantly peripheral; and 39 new vessels elsewhere, with 21 fields (53.8%) predominantly peripheral (Figure 3) . Of the 660 predominantly peripheral fields, 458 (69.4%) had hemorrhages and/or microaneurysms, 168 (25.5%) had intraretinal microvascular abnormalities, 21 (3.2%) had new vessels elsewhere, and 13 (2.0%) had venous beading. The distribution of specific predominantly peripheral DR lesions within individual eyes is shown in eFigure 3 in the Supplement. 
Discussion
Nearly all modern formal imaging assessments of DR severity have been based on grading the location and extent of key DR lesions within the ETDRS 7-standard field area. 1 However, given the technological advances now enabling UWF imaging and the potential benefits of this approach, 17 there may be substantial impetus for moving to UWF imaging if it is comparable in determining DR severity and if pathology in the retinal periphery provides additional clinically useful information on prospective worsening of retinopathy. 8, 11, 12 In this study, we found that ETDRS images had moderate agreement with UWF images that were masked to reveal only the ETDRS 7-field area, and substantial agreement after open adjudication of known discrepancies by 2 masked graders. Unpublished data from a Wisconsin reading center report exact agreement and agreement within 1 step between 2 graders evaluating the exact same ETDRS image to be 78% and 99%, respectively (Barbara Blodi, MD, written communication, December 26, 2017) . Predominantly peripheral lesions were common on UWF imaging, and results from this study showed that the UWF peripheral area may suggest increased DR severity by 2 or more steps in approximately 11.0% of eyes.
Although these data suggest that ETDRS and UWF imaging can both be used in clinical studies for assessing DR severity, it is important that the 2 imaging approaches do not visualize the exact same retinal area because of asynchronous image capture, manual positioning of each of the 7 ETDRS fields, and idealized ETDRS masking area used on the UWF masked images. Side-by-side comparison of the images derived from the 2 approaches was a crucial, preplanned component of this study to determine whether discrepancies were owing to inherent image quality, grading differences, or areas of retina visualized in 1 modality but not the other. Adjudication assessed whether each modality was more likely to accurately demonstrate presence of disease in an individual eye, or if the 2 imaging modalities were similar.
Both approaches to imaging were judged to similarly demonstrate retinopathy findings in more than half of the discrepant eyes. The major reason for the difference in eyes with 2 or more step discrepancy was grading errors. These cases were equivalently distributed between ETDRS and UWF masked images. Correcting these grading errors resulted ina2ormore step difference in DR severity in 3.1% of eyes. When either modality was identified as the more accurate images, the major reason for the difference was suboptimal image quality of the other modality. The suboptimal image quality was equally distributed between modalities. These findings further suggest that (1) the 2 imaging modalities are comparable for determining DR severity when following the protocol used in this study and (2) maximizing image quality is of paramount importance. Differences in field definition accounted for only a small percentage of discrepant cases.
As reported previously, unmasked UWF images frequently identified additional DR lesions in the retinal periphery. 12, 15, 18 Given that imaging of the ETDRS fields identifies a more severe DR level based on grading variability in approximately 1.0% of cases, UWF unmasked images likely suggest a net increase of DR severity in 10.0% of eyes. This is similar to prior reports of 9.0% to 15.0% of eyes.
5,11-13
Limitations A potentially important and yet unresolved issue regarding comparisons of 7-field and UWF imaging in management of DR concerns how an ophthalmologist might evaluate DR The total number of fields with any lesion observed is also presented. With respect to any lesion (n = 4504), those predominantlywithin the ETDRS 7 fields was 51.3%, those uniformly distributed were 34.0%, and those predominantly outside the ETDRS fields were 14.7%. For hemorrhage or microaneurysms (n = 3056), those values were 46.0%, 39.0%, and 15.0%, respectively; for intraretinal microvascular abnormalities (n = 1299), 63.3%, 23.8%, and 12.9%, respectively; for venous beading (n = 110), 63.6%, 24.6%, and 11.8%, respectively; for new vessels elsewhere (n = 39), 33.3%, 12.8%, and 53.9%, respectively.
Research Original Investigation
Comparison of ETDRS 7-Field and Ultrawide-Field Imaging for Determining Diabetic Retinopathy Severity severity in the clinic without an expert grader or adjudication and how such evaluation may change over time. However, important for clinical trials, the data from this analysis suggest that, following the protocol for this study, moderate to substantial agreement of DR severity is possible when comparing 7-field and UWF modalities across a diversity of DR stages. Another unresolved issue is the extent to which DR findings peripheral to the area of retina visualized with ETDRS 7-field imaging can affect the risk of DR progression. Future findings from the longitudinal data in this study might provide a definitive answer as to whether UWF images can improve methods to assess and triage eyes at risk for DR worsening.
Conclusions
The identification of a subset of patients at greatly increased risk of experiencing DR progression and onset of proliferative DR that cannot be assessed by ETDRS 7-field imaging would have important implications for the evaluation and care of diabetic eye disease. Not only would UWF devices be the preferred imaging modality, but their use would be important in clinical trial settings requiring precise assessment of prospective DR progression rates, in clinical care for accurate patient counseling, and in teleophthalmology programs to improve risk assessment and triage in eyes that otherwise would not have the peripheral retina evaluated. The current study suggests that enough patients have predominantly peripheral DR lesions at baseline to answer this question at the conclusion of this trial.
These baseline data show that ETDRS 7-field and UWF imaging can have moderate to substantial agreement when determining DR severity within the ETDRS area. These findings could justify UWF imaging for assessing DR severity end points in future studies. The use of UWF imaging in clinical settings not only increases the frequency of DR identification nearly 2-fold, but also reduces acquisition time by more than half, ungradable image rate by 71% (to <3%), and image evaluation time by 28% compared with nonmydriatic fundus photography.
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However, this study was performed with the assistance of a dedicated image grading center. Additional investigations may determine if these data hold true within the clinical setting or how UWF images perform in the development of artificial intelligence approaches. Furthermore, UWF imaging identifies peripheral lesions not captured by ETDRS imaging in a large percentage of eyes. Whether identification of these peripheral lesions will substantially affect the ability to assess the risk of future DR progression awaits final data from this ongoing study.
14. Gross JG, Glassman AR, Jampol LM, et Since there are so many potential patients with diseases of the eye, screening individuals and referring them for ophthalmic care can overwhelm the health care system. In response, advanced systems that use artificial intelligence to find people at risk need to be developed. The aim would be to create an expedient way of detecting pathology and referring patients for intervention early in the disease process.
The Diabetic Retinopathy Clinical Research Network (DRCRNet), a national group of concerned health care professionals, is looking at a current predecessor to this eventual solution. The DRCRNet was designed to collect data on a large, widely distributed sample of American individuals. The program coordinates the efforts of more than 400 clinicians at 115 separate independent health care facilities scattered across the country.
The study by Aiello et al 3 uses 37 DRCRNet sites to compare the Early Treatment Diabetic Retinopathy Study (ETDRS) 7-field system with an Ultrawide-Field (UWF) imaging system in finding diabetic retinopathy. The study goal was to determine which method is more effective in searching for diabetic ocular problems. A total of 742 patients had usable images from both procedures. The 2 different methods used in this study measure features of diabetic retinopathy well. The statistical techniques show that, for some diabetic lesions, there is an outstanding degree of correlation between the 2 systems, as demonstrated by the authors' weighted κ statistic. For that reason, this article will be cited repeatedly in future research studies.
A concern is that one cannot be sure if this information adds value for the typical physician caring for patients with diabetic eye disease. Of interest to the general ophthalmologist is the clinical relevance of the described features. Comparisons were made with the standard ETDRS photographic 7-field system by using techniques that masked parts of the UWF view. In that manner, the image examiners were looking at identical portions of the retina with the 2 different systems. In the past, the ETDRS photographic fields were described as the gold standard for discovering diabetic retinopathy, and methods used outside the United States were evaluated in terms of how well they matched the ETDRS. However, the ETDRS was developed decades ago, 4 and the world has changed. Ophthalmologists in clinical practice now use additional tools to make patient care decisions. The basic problem is that the UWF and the ETDRS examine planar (2-dimensional) images. Evaluating retinal thickness with either system is fraught with uncertainty. That is one reason why ocular coherent tomography is popular. The authors' statements 3 about comparison of imaging modalities within the same fields (ETDRS and UWF masked images) cause some concern. When the 2 techniques were used to examine identical fields, there was only a 48.4% agreement (n = 359 of 742). (Per unpublished data from another researcher, separate examinations of the same field in the ETDRS had an agreement of 78%.) The investigators show correlation with a weighted κ of 0.51 (95% CI, 0.44-0.58); this is much better than random agreement. But they are examining the exact same retinal fields. Are the optical properties of the 2 machines that different? Can the UWF be further refined? A lesion-by-lesion comparison is not included, so it is difficult to know if the UWF weakness thought to be within the 7 fields is balanced by the discovery of unknown predominantly peripheral lesions outside the 7 fields. That is, does new UWF information add enough to make it worth the cost of this new machine? Another concern is that this is a cross-sectional study. In other words, it is a report of a single sample taken at 1 specific moment. There is no mention of reproducibility over a time interval. There are no data about whether the values would be similar if reexamined a few hours later. Of equal importance, this single data biopsy permits no way to know if there may be other longitudinal problems. Would the results be equally good if this was done again in another month? A similar weighted κ method can be used to measure temporal changes. Here it could help show the reproducibility of these results. 
